Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Julia Kaiser"'
Publikováno v:
BMC Psychology, Vol 12, Iss 1, Pp 1-12 (2024)
Abstract Background Working alliance is a prominent non-specific factor for treatment outcomes in face-to-face and internet-based interventions. The association between working alliance and therapy outcome appears to be time- and disorder-specific, b
Externí odkaz:
https://doaj.org/article/e8f434c12bb74e70928169457f37f942
Publikováno v:
BMC Biology, Vol 20, Iss 1, Pp 1-19 (2022)
Abstract Background Stroke research heavily relies on rodent behavior when assessing underlying disease mechanisms and treatment efficacy. Although functional motor recovery is considered the primary targeted outcome, tests in rodents are still poorl
Externí odkaz:
https://doaj.org/article/a342132148a04ecb8a8732eaa5650b4d
Autor:
David T. Liu, Bernhard Prem, Gunjan Sharma, Julia Kaiser, Gerold Besser, Christian A. Mueller
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
BackgroundThe objective of this study was to determine how clinical characteristics and validated quality of life (QoL)-measures are associated with eating behavior in patients with olfactory dysfunction (OD).MethodsFor this cross-sectional study, 15
Externí odkaz:
https://doaj.org/article/de70fd972a434a3cacb18f4b3995a8ed
Autor:
Brane Grambozov, Evelyn Nussdorfer, Julia Kaiser, Sabine Gerum, Gerd Fastner, Markus Stana, Christoph Gaisberger, Romana Wass, Michael Studnicka, Felix Sedlmayer, Franz Zehentmayr
Publikováno v:
Current Oncology, Vol 28, Iss 3, Pp 1835-1846 (2021)
The treatment of locally recurrent lung cancer is a major challenge for radiation-oncologists, especially with data on high-dose reirradiation being limited to small retrospective studies. The aim of the present study is to assess overall survival (O
Externí odkaz:
https://doaj.org/article/1aee81276bee42fab08bea7e205e10a5
Publikováno v:
JMIR Mental Health, Vol 9, Iss 2, p e27642 (2022)
BackgroundBereavement due to cancer increases the risk of prolonged grief disorder. However, specialized treatment options for prolonged grief after a loss due to illness are still scarce. ObjectiveThe aim of this study is to extend previous finding
Externí odkaz:
https://doaj.org/article/bb23bb63d58641f8a162838c54184fd5
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0278271 (2022)
ObjectivesBefore the loss of a loved one to cancer, relatives have time to adapt to the impending death. However, due to the current COVID-19 pandemic, adjustment to an imminent death may be more difficult. This study investigates factors related to
Externí odkaz:
https://doaj.org/article/e9d5fbbdfbbb415083bd9ac1c52dbd0d
Publikováno v:
Thoracic Cancer, Vol 11, Iss 6, Pp 1375-1385 (2020)
Abstract Concomitant chemo‐radiotherapy (cCRT) with 60 Gy in 30 fractions is the standard of care for stage 111 non‐small cell lung cancer (NSCLC). With a median overall survival of 28.7 months at best and maximum locoregional control rates of 70
Externí odkaz:
https://doaj.org/article/1da86226b67148498dfbad00b1fe52ac
Autor:
Brane Grambozov, Frank Wolf, Julia Kaiser, Romana Wass, Gerd Fastner, Christoph Gaisberger, Lukas Rettenbacher, Michael Studnicka, Christian Pirich, Felix Sedlmayer, Franz Zehentmayr
Publikováno v:
Thoracic Cancer, Vol 11, Iss 2, Pp 369-378 (2020)
Abstract Background Chemoradiotherapy (CRT) is the standard treatment for patients with inoperable stage III non‐small cell lung cancer (NSCLC) stage III. With a median OS beyond 30 months, adequate pulmonary function (PF) is essential to ensure ac
Externí odkaz:
https://doaj.org/article/4c6cc4f9c1524b97b1106e976113aad8
Autor:
Jörg Zinken, Julia Kaiser, Matylda Weidner, Lorenza Mondada, Giovanni Rossi, Marja-Leena Sorjonen
Publikováno v:
Frontiers in Communication, Vol 6 (2021)
The present paper explores how rules are enforced and talked about in everyday life. Drawing on a corpus of board game recordings across European languages, we identify a sequential and praxeological context for rule talk. After a game rule is breach
Externí odkaz:
https://doaj.org/article/4400e058033248d3bfc8073991e81b83
Autor:
Michael Schroeter, Benjamin Berger, Franz Blaes, Tim Hagenacker, Sebastian Jander, Julia Kaiser, Petra Kalischewski, De-Hyung Lee, Tobias Ruck, Ulrike Schara, Peter Urban, Andreas Meisel
Publikováno v:
Journal of Central Nervous System Disease, Vol 13 (2021)
Background and purpose: In 2017, eculizumab has been approved for treatment-refractory generalised myasthenia gravis (TRgMG). The German Myasthenia Foundation has published a consensus statement on the use of eculizumab, with a recent update. However
Externí odkaz:
https://doaj.org/article/33bf1dde73f34835b88dde903da997cd